# FDA Inspection 1289322 - Cooper Institute for Advanced Reproductive Medicine - October 29, 2025

Source: https://www.keypedia.com/records/fda_inspections/cooper-institute-for-advanced-reproductive-medicine/7677e9bd-d6e0-4324-8740-842d869d9309
Source feed: FDA_Inspections

> FDA Inspection 1289322 for Cooper Institute for Advanced Reproductive Medicine on October 29, 2025. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1289322
- Company Name: Cooper Institute for Advanced Reproductive Medicine
- Inspection Date: 2025-10-29
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Dallas District Office

## Related Documents

- [FDA Inspection 1223634 - 2023-11-16](https://www.keypedia.com/records/fda_inspections/cooper-institute-for-advanced-reproductive-medicine/2719c59c-9256-4e84-9810-a17636f70f56)
- [FDA Inspection 1223634 - 2023-11-16](https://www.keypedia.com/records/fda_inspections/cooper-institute-for-advanced-reproductive-medicine/5ecd4332-c452-40e9-8ec4-fffebe53af6a)
- [FDA Inspection 1192782 - 2022-12-09](https://www.keypedia.com/records/fda_inspections/cooper-institute-for-advanced-reproductive-medicine/6232ec93-bf2f-4fde-bd76-80b268b4e462)
- [FDA Inspection 1192782 - 2022-12-09](https://www.keypedia.com/records/fda_inspections/cooper-institute-for-advanced-reproductive-medicine/76cd6431-6f1e-450d-91a7-c05c26d65be1)
- [FDA Inspection 1192782 - 2022-12-09](https://www.keypedia.com/records/fda_inspections/cooper-institute-for-advanced-reproductive-medicine/a08f15bc-9a4e-4d8b-8dc3-e656f3676f61)

Company: https://www.keypedia.com/companies/cooper-institute-for-advanced-reproductive-medicine/cd9a1da8-2714-4af0-9d40-c7bdb827234c

Office: https://www.keypedia.com/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9